PFIZER INC

Pfizer Inc. specializes in the manufacturing of sterile pharmaceutical preparations and biological products for federal medical and defense systems, with deep expertise in aseptic processing, lyophilization, and GMP-compliant production of injectables, tablets, and intravenous solutions. The contractor delivers critical medications—including furosemide, naloxone, ondansetron, and parenteral nutrition formulations—under strict FDA and DoD regulatory standards, ensuring batch consistency, sterility assurance, and cold chain integrity. Their technical capabilities span formulation development, vial filling, lyophilized product stabilization, and end-to-end pharmaceutical supply chain management, with demonstrated proficiency in producing high-risk, low-volume therapeutics for military and veteran healthcare needs. Pfizer maintains a primary relationship with the Department of Defense, supplying essential medications for field hospitals, combat support units, and military medical facilities. They also support the Department of Health and Human Services and the Department of Veterans Affairs with chronic care and emergency response pharmaceuticals, indicating a sustained role in sustaining the federal medical supply chain during both routine operations and public health contingencies. The contractor’s core industry focus is pharmaceutical preparation manufacturing (NAICS 325412), with supplementary activity in biological product manufacturing (NAICS 325414). This positions them as a specialized supplier of mission-critical injectables and oral solids, distinct from diagnostic or generic drug manufacturers. Their work supports military readiness, veteran pharmacotherapy, and public health preparedness through reliable, regulated production of high-complexity therapeutics. As a large-scale manufacturing entity structured as a 2L entity based in New York, Pfizer operates under full cGMP and FDA oversight with no public certifications beyond standard pharmaceutical licensure. Their geographic footprint supports national distribution, with manufacturing and logistics infrastructure calibrated to meet federal exigency requirements, establishing them as a trusted Tier-1 provider in the defense and federal healthcare pharmaceutical market.